Saurabh Saha Centessa Pharmaceuticals PLC (CNTA) insider trading activity
Saurabh Saha is Chief Executive Officer of Centessa Pharmaceuticals plc. Currently has a direct ownership of 429,398 shares of CNTA, which is worth approximately $7.28 Million. The most recent transaction as insider was on Jun 30, 2024, when has been sold 36,263 shares (Ordinary Shares) at a price of $9.03 per share, resulting in proceeds of $327,454. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
429K
31.91%
3M change
45.41%
12M change
Total Value Held
$7.28 Million
SAURABH SAHA Transaction History
Also insider at
SS
Saurabh Saha
Chief Executive Officer
Cheshire, X0